meerecompany Stock Forecast for 2023 - 2025 - 2030

Updated on 05/02/2024

Stock Rating
8
Price Target
₩0.00
Consensus
-
Downside
-61.34%
Analysts
0
Stock Rating
8
Downside
-61.34%
Analysts
0
Price Target
₩0.00
-

meerecompany Fair Value Forecast for 2023 - 2025 - 2030

In the last year, meerecompany's Price has decreased by 100.00%, going from ₩52.48k to ₩0.00. The next year looks promising for meerecompany, with analysts predicting Fair Value of ₩0.00 – an increase of 100.00%. Over the next six years, experts anticipate that meerecompany's Fair Value will grow at a rate of 100.00%.

2025 Fair Value Forecast
₩0.00
2026 Fair Value Forecast
₩0.00
2027 Fair Value Forecast
₩0.00
2028 Fair Value Forecast
₩0.00
2029 Fair Value Forecast
₩0.00
2030 Fair Value Forecast
₩0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
A005930 Stock Forecast Samsung Electronics Outperform 10
₩77.50k Buy/Sell ₩92.49k 29.03%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$151.18 Buy/Sell $174.55 12.45%
ISRG Stock Forecast Intuitive Surgical Outperform 13
$371.70 Buy/Sell $408.45 15.68%
MDT Stock Forecast Medtronic Outperform 11
$80.89 Buy/Sell $92.47 18.06%
A028260 Stock Forecast Samsung C&T Outperform 18
₩150.10k Buy/Sell ₩157.27k 21.59%

meerecompany Revenue Forecast for 2023 - 2025 - 2030

In the last two years, meerecompany's Revenue has grown, increasing from ₩58.94B to ₩154.86B – a growth of 162.72%. 0 analysts predict meerecompany's Revenue will decrease by 33.02% in the next year, reaching ₩103.73B. By 2030, professionals predict that meerecompany's Revenue will decrease by 26.89%, to ₩113.22B.

2023 Rev Forecast
₩103.73B
2024 Rev Forecast
₩95.12B
2025 Rev Forecast
₩105.74B
2026 Rev Forecast
₩122.76B
2027 Rev Forecast
₩116.69B
2028 Rev Forecast
₩109.41B
2029 Rev Forecast
₩108.68B
2030 Rev Forecast
₩113.22B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
7733 Stock Forecast Olympus Outperform 18
¥2.19k Buy/Sell ¥2.30k 9.54%
1066 Stock Forecast Shandong Weigao Group Medical ... Outperform 16
HK$5.34 Buy/Sell HK$11.68 33.33%
853 Stock Forecast MicroPort Scientific Outperform 6
HK$6.29 Buy/Sell HK$2.15 -80.76%

meerecompany Dividend per Share Forecast for 2023 - 2025 - 2030

meerecompany Free Cash Flow Forecast for 2023 - 2025 - 2030

meerecompany EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, meerecompany's EBITDA has grown by 290.74%, rising from ₩-14.72B to ₩28.07B. The next year, 0 experts forecast that meerecompany's EBITDA will decrease by 144.27%, reaching ₩-12.43B. In 2030, professionals predict that meerecompany's EBITDA will decrease by 205.96%, reaching ₩-29.74B.

2023 EBITDA Forecast
₩-12427847862.00
2024 EBITDA Forecast
₩-10987460294.79
2025 EBITDA Forecast
₩-20758974983.63
2026 EBITDA Forecast
₩-40958149608.54
2027 EBITDA Forecast
₩-29588167277.21
2028 EBITDA Forecast
₩-23871733359.25
2029 EBITDA Forecast
₩-24910949484.82
2030 EBITDA Forecast
₩-29744504049.86

meerecompany EBIT Forecast for 2023 - 2025 - 2030

In the last two years, meerecompany's EBIT has grown by 242.04%, rising from ₩-17.97B to ₩25.52B. According to the 0 analysts polled, in the next year, meerecompany's EBIT will fall by 218.32%, reaching ₩-30.20B. By 2030, professionals believe that meerecompany's EBIT will have decreased by 148.58%, falling to ₩-12.40B.

2023 EBIT Forecast
₩-30197914368.00
2024 EBIT Forecast
₩8.90B
2025 EBIT Forecast
₩-1087396027.41
2026 EBIT Forecast
₩-3494637106.36
2027 EBIT Forecast
₩-8279144768.69
2028 EBIT Forecast
₩-30139122644.44
2029 EBIT Forecast
₩-10126745208.53
2030 EBIT Forecast
₩-12398511716.98

meerecompany EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, meerecompany's EPS has decreased by 100.00%, going from ₩2601.75 to ₩0.00. The next year looks promising for meerecompany, with analysts predicting EPS of ₩0.00 – an increase of 100.00%. Over the next six years, experts anticipate that meerecompany's EPS will grow at a rate of 100.00%.

2025 EPS Forecast
₩0.00
2026 EPS Forecast
₩0.00
2027 EPS Forecast
₩0.00
2028 EPS Forecast
₩0.00
2029 EPS Forecast
₩0.00
2030 EPS Forecast
₩0.00